APOE and COVID-19: Interestingly, APOE4 has also been implicated as a risk factor for increased susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and COVID‐19 mortality in human patients and mouse models [10, 11].